GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
May 06, 2024 08:00 ET
|
Genetic Technologies Ltd
Genetic Technologies and 'Wellworks for You' sign B2B sales and marketing deal covering 750 employer groups and 2 million U.S. employees
Appendix 4C & Quarterly Business Update – March 2024
April 30, 2024 08:00 ET
|
Genetic Technologies Ltd
Quarterly Business Update; Launching our most comprehensive test and expanding into new global markets
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024
April 24, 2024 22:11 ET
|
Association québécoise des technologies (AQT)
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024Charlevoix (Québec), le 24 avril 2024 – C’est avec fierté que l’AQT
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
April 22, 2024 15:00 ET
|
Genetic Technologies Ltd
Genetic Technologies Announces Closing of $2 Million Registered Direct Offering
Leber Congenital Amaurosis Pipeline Insight 2024, Featuring Key Players ProQR Therapeutics, Editas Medicine, Atsena Therapeutics, Applied Genetic Technologies, IVERIC bio and MeiraGTx
April 22, 2024 07:51 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Leber congenital amaurosis - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides...
Genetic Technologies Announces $2 Million Registered Direct Offering
April 18, 2024 12:17 ET
|
Genetic Technologies Ltd
Genetic Technologies Announces $2 Million Registered Direct Offering
Muscular Dystrophy Association and Friedreich’s Ataxia Research Alliance Announce Collaborative Research Grant Using Novel Gene Editing Technology to Address Root Cause of Friedreich’s Ataxia Disease
April 17, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, April 17, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and Friedreich’s Ataxia Research Alliance (FARA) announced today a collaborative grant for $300,000 awarded to...
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
April 17, 2024 08:00 ET
|
Genetic Technologies Ltd
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Kamari Pharma Announces Abstracts Accepted for Presentation at the 81st Annual Meeting of the Society for Investigative Dermatology
April 16, 2024 16:05 ET
|
Kamari Pharma
Late breaking poster presentation includes Phase 1b clinical trial results demonstrating the safety and preliminary efficacy of KM-001, a topical TRPV3 inhibitor, for the treatment of palmoplantar...
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
April 16, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year